Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer

This publication has 12 references indexed in Scilit:

• Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer
  Cancer Chemotherapy and Pharmacology, 1991
• A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer
  British Journal of Cancer, 1990
• Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?
  Cancer, 1989
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
  Journal of Clinical Oncology, 1988
• Therapy with cisplatin and etoposide for non-small-cell lung cancer.
  1986
• Vindesine and mitomycin in the treatment of advanced non-small cell lung cancer: a Southeastern Cancer Study Group Trial.
  1986
• Phase II Study of the Three-Drug Combination of Mitomycin C, CCNU, and Methotrexate (MCM) in Advanced Non-Small Cell Lung Cancer
  American Journal of Clinical Oncology, 1986
• Cis-platinum and vindesine in combination in the treatment of non-small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1985
• RANDOMIZED TRIAL COMPARING VINDESINE PLUS CISPLATIN WITH VINBLASTINE PLUS CISPLATIN IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER, WITH AN ANALYSIS OF METHODS OF RESPONSE ASSESSMENT
  1985
• Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
  1984